CT-based texture analysis potentially provides prognostic information complementary to interim fdg-pet for patients with hodgkin’s and aggressive non-hodgkin’s lymphomas

por Ganeshan, B., Miles, K. A., Babikir, S., Shortman, R., Afaq, A., Ardeshna, K. M., Groves, A. M., Kayani, I.
Publicado 2016

Diffuse large B cell lymphoma (DLBCL) in patients older than 65 years: analysis of 3 year Real World data of practice patterns and outcomes in England

por Hounsome, L., Eyre, T. A., Ireland, R., Hodson, A., Walewska, R., Ardeshna, K., Chaganti, S., McKay, P., Davies, A., Fox, C. P., Kalakonda, N., Fields, P. A.
Publicado 2021

Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial()

por McMillan, A.K., Phillips, E.H., Kirkwood, A.A., Barrans, S., Burton, C., Rule, S., Patmore, R., Pettengell, R., Ardeshna, K.M., Lawrie, A., Montoto, S., Paneesha, S., Clifton-Hadley, L., Linch, D.C.
Publicado 2020

Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial

por Gleeson, M., Counsell, N., Cunningham, D., Chadwick, N., Lawrie, A., Hawkes, E. A., McMillan, A., Ardeshna, K. M., Jack, A., Smith, P., Mouncey, P., Pocock, C., Radford, J. A., Davies, J., Turner, D., Kruger, A., Johnson, P., Gambell, J., Linch, D.
Publicado 2017

Outcome of elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics w...

por Kühnl, A., Cunningham, D., Counsell, N., Hawkes, E. A., Qian, W., Smith, P., Chadwick, N., Lawrie, A., Mouncey, P., Jack, A., Pocock, C., Ardeshna, K. M., Radford, J., McMillan, A., Davies, J., Turner, D., Kruger, A., Johnson, P. W., Gambell, J., Rosenwald, A., Ott, G., Horn, H., Ziepert, M., Pfreundschuh, M., Linch, D.
Publicado 2017

P1187: END OF TREATMENT 18F FDG-PET/CT RESPONSE IS PROGNOSTIC FOR OVERALL AND PROGRESSION-FREE SURVIVAL IN PERIPHERAL T-CELL LYMPHOMA: RESULTS OF THE UK NCRI PHASE 2 RANDOMISED CHE...

por Gleeson, M., Arias, C., Cunningham, D., Peckitt, C., Du, Y., Hujairi, N., To, Y. M., Chen, H.-C., Patel, S., Chau, I., Johnson, P., Ardeshna, K. M., Wotherspoon, A., Attygalle, A., Hawkes, E. A., Macheta, M. P., Collins, G. P., Radford, J., Forbes, A., Hart, A., Montoto, S., McKay, P., Benstead, K., Morley, N., Kalakonda, N., Hasan, Y., Turner, D., Chua, S.
Publicado 2022

P1162: ZANUBRUTINIB IN OLDER PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): SUBGROUP ANALYSIS OF THE MAGNOLIA STUDY

por Opat, S., Hu, B., Tedeschi, A., Linton, K. M., McKay, P., Chan, H., Jin, J., Sun, M., Sobieraj-Teague, M., Zinzani, P. L., Coleman, M., Browett, P., Ke, X., Portell, C. A., Thieblemont, C., Ardeshna, K., Bijou, F., Walker, P., Hawkes, E. A., Ho, S.-J., Zhou, K.-S., Co, M., Xu, J., Liang, Z., Anderson, J., Tankersley, C., Huang, J., Trotman, J.
Publicado 2022